Penn Medicine Abramson Cancer Center

 

Penn Medicine Abramson Cancer Center
S

Phase II Trial of Intraoperative Molecular Imaging of Lung Cancer with Cathepsin Imaging

By Penn Medicine Abramson Cancer Center FEATURING Sunil Singhal
By Penn Medicine Abramson Cancer Center FEATURING Sunil Singhal
0 views
January 5, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Precision Surgery Intraoperative Molecular Imaging 2022
31:08
Penn Medicine Abramson Cancer Center

pH Sensitive Dyes: Bench to Bedside (and Back to the Bench Again)

Feat. B. Sumer
14:51
Penn Medicine Abramson Cancer Center

Multispectral Imaging Sensors

Feat. V. Gruev
13:06
Penn Medicine Abramson Cancer Center

New Generation Photoacoustic Imaging: From Benchtop to Bedside

Feat. L. Li
21:01
Penn Medicine Abramson Cancer Center

Label-Free Fluorescence Lifetime Imaging: Applications in Surgical O…

Feat. L. Marcu
19:01
Penn Medicine Abramson Cancer Center

Clinical Fluorescence Lifetime Imaging Using Exogenous Probes

Feat. A. Kumar
16:46
Penn Medicine Abramson Cancer Center

Intraoperative Molecular Imaging in Oncology: NCI Perspective and Re…

Feat. L. Shankar
21:11
Penn Medicine Abramson Cancer Center

Choline Kinase Targeted NIR Dyes for Intraoperative Molecular Imagin…

Feat. E. Delikatny
15:45
Penn Medicine Abramson Cancer Center

IS-001 Intraoperative Ureteral Fluorescent Visualization

Feat. R. Farnam
14:01
Penn Medicine Abramson Cancer Center

Near Infrared Contrast Agents for Nerve Imaging

Feat. S. Gibbs
14:29
Penn Medicine Abramson Cancer Center

Nerve Specific Dyes: Normal Tissue Identification

Feat. R. Orosco
11:39
Penn Medicine Abramson Cancer Center

Near Infrared Fluorescent Imaging Brain Tumors

Feat. J. Lee
08:11
Penn Medicine Abramson Cancer Center

Urokinase-Type Plasminogen Activator Receptor Targeting Dye

Feat. J. Skjoth-Rasmussen
14:55
Penn Medicine Abramson Cancer Center

EGFR-Targeted Fluorescence Guidance in Connective Tissue Oncology

Feat. E. Henderson
18:54
Penn Medicine Abramson Cancer Center

Intraoperative Molecular Imaging for Pediatric Solid Tumors

Feat. M. Malek
15:58
Penn Medicine Abramson Cancer Center

Clinical Experience Using ICG

Feat. A. Abdelhafeez
17:35
Penn Medicine Abramson Cancer Center

Optimizing Maximal Safe Brain Tumor Resection With Tozuleristide

Feat. A. Lee
14:48
Penn Medicine Abramson Cancer Center

Multi-Institutional Phase 2 Trial of Pegsitacianine for Intraoperati…

Feat. D. Rice
10:21
Penn Medicine Abramson Cancer Center

Detection of Residual Peritoneal Metastases Following Cytoreductive …

Feat. P. Wagner
19:30
Penn Medicine Abramson Cancer Center

Phase II Trial of Intraoperative Molecular Imaging of Lung Cancer wi…

Feat. S. Singhal
21:24
Penn Medicine Abramson Cancer Center

Anti-EGFR Antibody Imaging Strategies for Real-Time Surgical and Pat…

Feat. E. Rosenthal
18:31
Penn Medicine Abramson Cancer Center

Protease Activated Dye in Breast Cancer Surgery: Multicenter, Random…

Feat. B. Smith
12:29
Penn Medicine Abramson Cancer Center

CEA Colorectal Cancer Phase 3 Trial

Feat. A. Vahrmeijer
15:50
Penn Medicine Abramson Cancer Center

Results of the Randomized, Multi-Center Phase 3 ELUCIDATE Trial: Paf…

Feat. L. Martin
13:14
Penn Medicine Abramson Cancer Center

Phase 3, Randomized, Single-Dose, Open-Label Study to Investigate th…

Feat. J. Tanyi
15:36
Penn Medicine Abramson Cancer Center

5-ALA in Europe: Future Steps

Feat. W. Stummer